Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis

被引:24
作者
Hinoi, E
Ohashi, R
Miyata, S
Kato, Y
Iemata, M
Hojo, H
Takarada, T
Yoneda, Y [1 ]
机构
[1] Kanazawa Univ, Grad Sch Nat Sci & Technol, Mol Pharmacol Lab, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
[2] Astellas Pharma Inc, Pharmacol Res Labs, Osaka 5328514, Japan
关键词
EAATs; glutamate; rheumatoid arthritis; H-3]glutamate accumulation; cell proliferation; synovial fibroblasts; GluRs;
D O I
10.1016/j.bcp.2005.09.010
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Although previous studies have demonstrated increased levels of the brain neurotransmitter glutamate (Glu) in the synovial fluid from patients with arthritis, not much attention has been paid to the possible role of Glu in joint synovial tissues to date. Constitutive expression of mRNA was for the first time shown with glutamate aspartate transporter, glutamate transporter-1 and excitatory amino acid carrier-1 (EAAC1), in addition to with particular ionotropic and metabotropic Gin receptors, in cultured synovial fibroblasts prepared from knee joints of male Lewis rats. Immunohistochemical analysis revealed high localization of immunoreactive EAAC1 at synovial tissues. The accumulation of [H-3]Glu occurred in a temperature- and sodium-dependent manner in cultured synovial fibroblasts, with a Km of 23.1 +/- 1.1 mu M and a V-max of 237.1 +/- 31.1 pmol(mg protein min), respectively. In rats with arthritis induced by immunization to type-II collagen, marked increases were seen in hind paw volume, cytokine mRNA expression and Glu levels in synovial tissues, in addition to histological erosion. In cultured synovial fibroblasts prepared from these arthritic rats, [H-3]Glu accumulation was drastically increased with biochemical and pharmacological profiles similar to those seen in normal synovial fibroblasts. The exposure to Glu at 500 mu M doubled the incorporation of 5-bromo-2'-deoxyuridine in cultured synovial fibroblasts of arthritic but not normal rats, without significantly affecting mRNA expression of different cytokines in both synovial fibroblasts. These results suggest that Glu may at least in part play a role in mechanisms associated with cellular proliferation through particular transporters functionally expressed by synovium in rheumatoid arthritis. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1744 / 1755
页数:12
相关论文
共 46 条
[1]
Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS [J].
Atkinson, L ;
Batten, TFC ;
Moores, TS ;
Varocqui, H ;
Erickson, JD ;
Deuchars, J .
NEUROSCIENCE, 2004, 123 (03) :761-768
[2]
BANNAI S, 1986, J BIOL CHEM, V261, P2256
[3]
Characterization of cystine uptake in cultured astrocytes [J].
Bender, AS ;
Reichelt, W ;
Norenberg, MD .
NEUROCHEMISTRY INTERNATIONAL, 2000, 37 (2-3) :269-276
[4]
A NONINDUCIBLE CYSTINE TRANSPORT-SYSTEM IN RAT ALVEOLAR TYPE-II CELLS [J].
BUKOWSKI, DM ;
DENEKE, SM ;
LAWRENCE, RA ;
JENKINSON, SG .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (01) :L21-L26
[5]
IDENTIFICATION OF 3 MAJOR SYNOVIAL LINING CELL-POPULATIONS BY MONOCLONAL-ANTIBODIES DIRECTED TO IA ANTIGENS AND ANTIGENS ASSOCIATED WITH MONOCYTES MACROPHAGES AND FIBROBLASTS [J].
BURMESTER, GR ;
DIMITRIUBONA, A ;
WATERS, SJ ;
WINCHESTER, RJ .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 17 (01) :69-82
[6]
Glutamate uptake [J].
Danbolt, NC .
PROGRESS IN NEUROBIOLOGY, 2001, 65 (01) :1-105
[7]
Pathogenesis of arthritis: recent research progress [J].
Feldmann, M .
NATURE IMMUNOLOGY, 2001, 2 (09) :771-773
[8]
Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[9]
Glial transporters for glutamate, glycine and GABA I.: Glutamate transporters [J].
Gadea, A ;
López-Colomé, AM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 63 (06) :453-460
[10]
Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage [J].
Hinoi, E ;
Wang, LY ;
Takemori, A ;
Yoneda, Y .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (01) :70-81